{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 3405,
  "pageSize": 60,
  "pageCount": 5333,
  "rows": [
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide features a thumbnail of a scientific poster titled 'Breaking barriers to access intracellular targets with T-cell engagers'.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/7",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-7",
      "loopMatches": [
        {
          "to": 7,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "ef4b542e-5e1c-4ccf-8641-084f7bec094c",
          "evidence": "The executive summary and key takeaways suggest a golden circle loop.",
          "position": 1,
          "objective": "Why is AbCellera's approach to T-cell engagers important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "c8821ac2-b192-450b-863f-b9ed3e9b06b3",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The key takeaways on page 7 provide a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "thesis_headline",
      "function": "summarize",
      "notes": "The slide uses a dark overlay on a photo of people working, with a prominent callout box for the key achievement.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/8",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 8,
          "beatId": "bc30268d-0040-4598-9fd1-79d4d89c4482",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The thesis headlines on pages 8-9 provide evidence and proof.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "thesis_headline",
      "function": "summarize",
      "notes": "The slide uses a dark overlay on a professional photo to emphasize the text.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/9",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 8,
          "beatId": "bc30268d-0040-4598-9fd1-79d4d89c4482",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The thesis headlines on pages 8-9 provide evidence and proof.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "Uses a three-pillar strategic framework for capital allocation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/10",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 10,
          "beatId": "dac3d9dc-9052-4225-8ada-f6819af13828",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The key messages on page 10 outline impact and next steps.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/11",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a combination of big numbers and stacked bar charts to visualize cumulative growth over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/12",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide highlights a new undisclosed molecule in Phase 1.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/13",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart uses a broken axis for the Q1 2022 bar to accommodate the large royalty component.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/14",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a waterfall-style annotation to show the absolute dollar increase between the two periods.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/15",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a side-by-side bar chart comparison for three metrics: Net Earnings, Basic EPS, and Diluted EPS.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/16",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart illustrates the bridge between two balance sheet dates using cash flow categories.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/17",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c961-75ce-9ec9-a463e48376df",
      "docSlug": "54709ba209601bcbd02096c2ee161b23",
      "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/18",
      "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
      "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/hvUR_xrAEjm5Pr06fkAzN7BZvOz6Yc1tvEXlDm89-mY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MTZkM2IxZjNiNDc2MjEyYmNlYTU0NTc4NDcyMjVmMS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/1",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "192534c4-2581-4d66-86b6-ef3ed76890c8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, disclaimer, and key messages slides provide an introduction to the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/INQFDSn-2NKtcIZ9T7BCKxEeDtBmqmwFb6YM18ifdZQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MTZkM2IxZjNiNDc2MjEyYmNlYTU0NTc4NDcyMjVmMS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/k3lVG0KKy9rgxIxLM03eXef9Vz5A-7EVrJjCZHmWKAY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MTZkM2IxZjNiNDc2MjEyYmNlYTU0NTc4NDcyMjVmMS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/ck8YxXxm0rTt5xcJ0Dbj-boBvqx6m6NAOVTpoAuUDXk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MTZkM2IxZjNiNDc2MjEyYmNlYTU0NTc4NDcyMjVmMS9wMDAxLnBuZw"
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/2",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "192534c4-2581-4d66-86b6-ef3ed76890c8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, disclaimer, and key messages slides provide an introduction to the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/3",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-3",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "44fafb4b-5248-4c23-a33e-cd9b91839271",
          "evidence": "The key messages and financial results slides provide a clear logic chain.",
          "position": 0,
          "objective": "Understand the company's financial performance",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "192534c4-2581-4d66-86b6-ef3ed76890c8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, disclaimer, and key messages slides provide an introduction to the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a structured table-like layout to compare two key metrics across three business units.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/4",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-4",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "44fafb4b-5248-4c23-a33e-cd9b91839271",
          "evidence": "The key messages and financial results slides provide a clear logic chain.",
          "position": 0,
          "objective": "Understand the company's financial performance",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 6,
          "from": 4,
          "name": "Voice Of Customer",
          "slug": "51-voice-of-customer",
          "bestFor": "Product strategy, customer experience, market research",
          "matchId": "765e3de8-316b-4424-85ea-4aae624bccd2",
          "evidence": "The healthy revenue trends slide provides insight into the company's performance.",
          "position": 1,
          "objective": "Show healthy revenue trends",
          "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
          "confidence": 0.6,
          "description": "Let customer quotes and feedback drive the narrative and validate the insight"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "cccd2de8-0013-4ead-871f-0157ecbbdef1",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "The Q1 financial results, healthy revenue trends, and capitalization summary slides provide evidence of the company's performance.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart shows a multi-year trend of in-store sampling events, with a specific callout for +27% YOY growth.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/5",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-5",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "44fafb4b-5248-4c23-a33e-cd9b91839271",
          "evidence": "The key messages and financial results slides provide a clear logic chain.",
          "position": 0,
          "objective": "Understand the company's financial performance",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 6,
          "from": 4,
          "name": "Voice Of Customer",
          "slug": "51-voice-of-customer",
          "bestFor": "Product strategy, customer experience, market research",
          "matchId": "765e3de8-316b-4424-85ea-4aae624bccd2",
          "evidence": "The healthy revenue trends slide provides insight into the company's performance.",
          "position": 1,
          "objective": "Show healthy revenue trends",
          "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
          "confidence": 0.6,
          "description": "Let customer quotes and feedback drive the narrative and validate the insight"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "cccd2de8-0013-4ead-871f-0157ecbbdef1",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "The Q1 financial results, healthy revenue trends, and capitalization summary slides provide evidence of the company's performance.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "kpi_overview",
      "function": "summarize",
      "notes": "Includes a visual representation of debt maturity and a callout regarding interest rate hedging.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/6",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-6",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "44fafb4b-5248-4c23-a33e-cd9b91839271",
          "evidence": "The key messages and financial results slides provide a clear logic chain.",
          "position": 0,
          "objective": "Understand the company's financial performance",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 6,
          "from": 4,
          "name": "Voice Of Customer",
          "slug": "51-voice-of-customer",
          "bestFor": "Product strategy, customer experience, market research",
          "matchId": "765e3de8-316b-4424-85ea-4aae624bccd2",
          "evidence": "The healthy revenue trends slide provides insight into the company's performance.",
          "position": 1,
          "objective": "Show healthy revenue trends",
          "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
          "confidence": 0.6,
          "description": "Let customer quotes and feedback drive the narrative and validate the insight"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "cccd2de8-0013-4ead-871f-0157ecbbdef1",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "The Q1 financial results, healthy revenue trends, and capitalization summary slides provide evidence of the company's performance.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "appendix_disclosure",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/7",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes footnotes (1) through (9) referenced in the table rows.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/8",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide presents two separate tables for Sales and Marketing segments, detailing various add-backs to operating income.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/9",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes footnotes referencing specific adjustments (10-13).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/10",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/11",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "appendix_disclosure",
      "function": "appendix",
      "notes": "This slide provides the definitions for the numbered references used in the preceding non-GAAP reconciliation tables.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/12",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4e139d3-e698-4436-8908-78cb3cf43b5e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Appendix",
          "beatSlug": null,
          "evidence": "The non-GAAP reconciliation slides provide additional detailed information.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-c9fa-7410-973a-4a82f7aad379",
      "docSlug": "516d3b1f3b476212bcea5457847225f1",
      "documentTitle": "Advantage Solutions | Results Presentation Deck | 13 slides",
      "authorId": "advantage-solutions",
      "authorName": "Advantage Solutions",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-c9fa-7410-973a-4a82f7aad379/13",
      "deckHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379",
      "deckAnchorHref": "/decks/019de074-c9fa-7410-973a-4a82f7aad379#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 13,
          "beatId": "2eb3c7e7-b732-4cef-9d38-756f0bbf706e",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Reflection",
          "beatSlug": "reflection",
          "evidence": "The closing ask slide provides a conclusion to the presentation.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/-i2208skPuCniXMhiiNFv3qxSd1iRKkpDHj7ETVRPhU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDc1NDU4OGFhMjViMzIwNzlhZjA1NWQ1MTExM2IwMy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/1",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/_tLp0P--RWQCD7PWOokHhsjheciJFfWqicB-JMqE_q4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDc1NDU4OGFhMjViMzIwNzlhZjA1NWQ1MTExM2IwMy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/n2Du5fcErCdtQVJELa3fONz2JvgzXUywnwrHo123B18/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDc1NDU4OGFhMjViMzIwNzlhZjA1NWQ1MTExM2IwMy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/827bMg6G--12pJvb3K2G8Kej65TeMohwnkYZWHKMZq8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDc1NDU4OGFhMjViMzIwNzlhZjA1NWQ1MTExM2IwMy9wMDAxLnBuZw"
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/2",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "traction",
      "function": "show_traction",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/3",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style chart to represent clinical trial progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/4",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/5",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/6",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 6,
          "beatId": "c4e487ac-8a01-4994-ad56-e8b0b8ab2867",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 6-8 present the problem of Classical Homocystinuria and its complications",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "pain_points",
      "function": "frame_problem",
      "notes": "Includes testimonials from KOLs to emphasize the difficulty of patient compliance.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/7",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 6,
          "beatId": "c4e487ac-8a01-4994-ad56-e8b0b8ab2867",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 6-8 present the problem of Classical Homocystinuria and its complications",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 7,
          "from": 7,
          "beatId": "ccd7b04a-0602-4c8a-a924-a051b6fc8fa9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitation",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "Slide 7 highlights the risks associated with persistently high total homocysteine levels",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a pie chart to segment patients and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/8",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 6,
          "beatId": "c4e487ac-8a01-4994-ad56-e8b0b8ab2867",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 6-8 present the problem of Classical Homocystinuria and its complications",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a biological process diagram showing intracellular vs plasma metabolism.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/9",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 9,
          "beatId": "3328461c-115b-4203-92b7-1e5b2aa4a11c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slide 9 presents Pegtarviliase as an innovative enzyme approach to lowering homocysteine",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a multi-part clinical trial design with specific dosing cohorts and eligibility requirements.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/10",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 10,
          "beatId": "b32cfa0c-61fe-428f-a501-3e7c1727ffcf",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 10-11 present the Phase 1/2 clinical trial design and interim results for Pegtarviliase",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart displays efficacy data for a drug candidate (pegtarviliase) across different dosage cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/11",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 10,
          "beatId": "b32cfa0c-61fe-428f-a501-3e7c1727ffcf",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "Slides 10-11 present the Phase 1/2 clinical trial design and interim results for Pegtarviliase",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/12",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "ADA stands for Anti-Drug Antibodies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/13",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/14",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a timeline-based progression of symptoms to illustrate the severity of the disease.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/15",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide uses a two-column layout to contrast commercial/regulatory status with clinical trial outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/16",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes box plots for arginine levels and bar charts for patient normalization rates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/17",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Clinical trial data presentation with statistical significance markers and MCID thresholds.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/18",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a heatmap to display individual patient outcomes across four metrics (pArg, GMFM-E, 2MWT, GMFM-D).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/19",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/20",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/21",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/22",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide presents a standard quarterly financial comparison (P&L summary) and balance sheet highlights.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/23",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/24",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/25",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-25",
      "loopMatches": [
        {
          "to": 25,
          "from": 25,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "a7076355-50ef-4e85-83d2-dbb3f7d91f51",
          "evidence": "Slide 25 presents Pegtarviliase as an engineered human enzyme that metabolizes multiple forms of free homocysteine",
          "position": 1,
          "objective": "Show the potential benefits of Pegtarviliase",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.7,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a Kaplan-Meier survival curve and a comparative table to illustrate the severity of the disease.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/26",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-26",
      "loopMatches": [
        {
          "to": 26,
          "from": 26,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b9b43972-9994-4cab-98b1-63f76f39fcdd",
          "evidence": "Slide 26 presents the increased mortality and high risk of severe complications associated with Classical Homocystinuria",
          "position": 0,
          "objective": "Highlight the risks of not treating Classical Homocystinuria",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.8,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide includes experimental design details and statistical significance markers (p < 0.05).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/27",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes survival curve (Kaplan-Meier) and pharmacodynamic response (tHcy levels over time).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/28",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes histological images of liver tissue and a dot plot showing bone mineral density (BMD) improvement.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/29",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays mean/SD, range, and counts/percentages for Pegzilarginase (n=21), Placebo (n=11), and Overall (N=32).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/30",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data includes Plasma Arginine, GMFCS level, GMFM-E, and 2MWT metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/31",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart is a box-and-whisker plot showing longitudinal data from baseline through 56 weeks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/32",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "Includes both continuous mean change data and categorical responder analysis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/33",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a study design timeline at the bottom right and MCID reference lines on the GMFM-E chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/34",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "docSlug": "6d754588aa25b32079af055d51113b03",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "context",
      "function": "establish_context",
      "notes": "Slide details GMFCS classification levels and GMFM/Timed Walk Test methodologies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/35",
      "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
      "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 38,
          "from": 3,
          "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}